Inflammation/Immunology

ALK5-IN-7 is a potent inhibitor of ALK5. Transforming growth factor beta (TGF-β) is a multifunctional cytokine that is involved in regulating cell proliferation, differentiation and apoptosis through complex receptor signaling pathways on the cell surface in an autocrine, paracrine and endocrine manner. ALK5-IN-7 has the potential for the research of TGF-β-related diseases and conditions, including but not limited to tumors, fibrotic diseases, inflammatory diseases, autoimmune diseases, etc (extracted from patent WO2021129621A1, compound 4).

DOPE-PEG5000-WYRGRL is a functionalized PEGylated lipid conjugate composed of three modular components: dioleoylphosphatidylethanolamine (DOPE) as the lipid anchoring group, a polyethylene glycol (PEG) spacer arm with a molecular weight of 5000 Da, and WYRGRL peptide (HY-P10739)as the terminal targeting/functional ligand. DOPE-PEG5000-WYRGRL can be incorporated into liposomes, lipid nanoparticles (LNPs), or other nanocarriers to confer ligand-directed targeting capability against specific cell surface receptors in tumor and inflammatory microenvironments.

Pennyroyal oil (mentha pulegium) is a natural essential oil extracted from the peppermint plant and can be used in research on gastrointestinal diseases, dysmenorrhea, and respiratory diseases.

Scrophularia ningpoensis extract is an orally effective hypoglycemic and antioxidant agent. Scrophularia ningpoensis extract reduces fasting blood glucose levels, increases plasma insulin levels, ameliorates impaired antioxidant status, scavenges free radicals, inhibits lipid peroxidation, and decreases elevated serum creatinine and serum urea levels. Scrophularia ningpoensis extract reduces the risk of developing diabetic complications. Scrophularia ningpoensis extract is applicable to diabetes-related research.

(22E,24R)-23-Methylergosta-7,22-diene-3β,5α,6β-triol (Compound 7) is an Ergosteroid. (22E,24R)-23-Methylergosta-7,22-diene-3β,5α,6β-triol can be isolated from Penicillium herquei. (22E,24R)-23-Methylergosta-7,22-diene-3β,5α,6β-triol exhibits no obvious inhibitory activities against NO production induced by LPS.

Sinulatumolin D (compound 4) is an anti-inflammatory agent. Sinulatumolin D has significant TNF-α inhibitory activity with an IC₅₀ value of 5.5 μM.

Sophora alopecuroides seed extract is an extract of sophora alopecuroides that has anti-inflammatory activity.

RIPK2-IN-6 (Compound 15a) is an inhibitor for RIPK, that inhibits the phosphorylation of RIPK2, and thus inhibits the NF-κB and MAPK signaling pathways. RIPK2-IN-6 exhibits anti-inflammatory and anti-fibrotic activities in Dextran sodium sulfate (HY-116282C)-induced mice colitis models.

Flavidin, an aromatic compound, can be isolated from Coelogyne longipe. Flavidin is an antioxidant, and has radical scavenging activity.

BTK-IN-6 is a potent inhibitor of Bruton's Tyrosine Kinase (BTK). BTK is a member of the Tec family of tyrosine kinases and plays an important role in the regulation of early B-cell development and mature B-cell activation and survival. BTK-IN-6 has the potential for the research of immune disorders, cancer, cardiovascular diseases, viral infections, inflammation, metabolism/endocrine function disorders, and neurological disorders (extracted from patent WO2021136219A1, compound 8).

β-Aminoarteether maleate (SM934) is an Artemisinin derivative with orally active. β-Aminoarteether maleate can be used for inflammation and autoimmune disease research, such as lupus diseases.

(R,R)-Secoisolariciresinol diglucoside-d₆ is deuterated labeled (R,R)-Secoisolariciresinol diglucoside (HY-N6937). (R,R)-Secoisolariciresinol diglucoside ((R,R)-SDG) is the minor isomer of Secoisolariciresinol diglucoside in flaxseed. (R,R)-Secoisolariciresinol diglucoside ((R,R)-SDG) possesses antioxidant and free radical scavenging activities and DNA-radioprotective properties. (R,R)-Secoisolariciresinol diglucoside ((R,R)-SDG) inhibits myeloperoxidase (MPO) activity by suppressing both the peroxidase and chlorination cyclesin inflammatory cells.

Anti-CD300C Antibody is a monoclonal antibody targeting CD300C. It can be used in ELISA, FACS, and functional assays. For isotype controls of Anti-CD300C Antibody, please refer to Human IgG1 kappa, Isotype Control (HY-P99001).

IRAK4-IN-28 (compound 42) is an orally active IRAK4 inhibitor (IC₅₀=8.9 nM). IRAK4-IN-28 has binding affinity for IRAK4 with a Kd of 0.58 nM. IRAK4-IN-28 can be used in the research of inflammation and autoimmune diseases.

Anti-CD99 Antibody is a monoclonal antibody that targets CD99. It can be used in ELISA, FACS, and functional assays. For isotype controls of Anti-CD99 Antibody, please refer to Human IgG1 kappa, Isotype Control (HY-P99001).

Monophosphoryl lipid A (Triethylamine) is a toll-like receptor 4 agonist. Monophosphoryl lipid A (Triethylamine) is derived from the cell wall of nonpathogenic Salmonella. Monophosphoryl lipid A (Triethylamine) can be used for the research of immunization and vaccine.

CDK8-IN-15 (Compound 46) is a potent CDK8 inhibitors with an IC₅₀ value of 57 nM. It can enhance the thermal stability of CDK8 along with inhibition against NF-κB and have favourable selectivity across the CDK family and tyrosine kinase. Additionally, it also demostrates a positive effect in vitro psoriasis model induced by TNF-α and alleviats the inflammatory response enhancing the expression of Foxp3 and IL-10, which is promising for research of psoriasis diseases.

GW-3333 is a potent and orally active TNF-alpha-converting enzyme (TACE) and matrix metalloproteinases (MMP) inhibitor. GW-3333 inhibits tumor necrosis factor-alpha (TNF-alpha) production. GW-3333 can be used in research of arthritis.

TAS266 is a tetrameric nanobody agonist targeting DR5. TAS266 selectively induces cancer cell death. TAS266 triggers sustained tumor regression in xenograft models and also elicits immunogenic responses including antibody binding. TAS266 exhibits superior anti-tumor efficacy compared with traditional DR5-targeting strategies. TAS266 can be used in research related to pancreatic cancer and advanced solid tumors.

COX-2/5-LOX-IN-7 (Hybrids 9) is a COX-2 (IC₅₀ = 3.3 μM)/5-LOX (IC₅₀ = 3.1 μM) inhibitor. COX-2/5-LOX-IN-7 can be used in research on diseases such as inflammation.